top of page


News
Categories
Sign up
Featured Posts


Archive


- Dec 14, 2022
Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event
JERUSALEM, December 13, 2022 -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to present at the Biotech Showcase™ and host institutional investor meetings at this event, as well as at the LifeSci Partners Corporate Access Event. Both in-person events are taking place in parallel with the 41st Annual J.P. Morgan Healthcare Conferenc
bottom of page